Get paper from

journal cover

Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?

Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy

Apr 5, 2012

U Deniz Dincer

Get paper from

Abstract

Metabolic syndrome is characterized by a combination of obesity, hypertension, insulin resistance, dyslipidemia, and impaired glucose tolerance. This multifaceted syndrome is often accompanied by a hyperdynamic circulatory state characterized by increased blood pressure, total blood vol...read more

Mentioned in this Paper

Cerebral Arterial Diseases
Ryanodine Receptor Calcium Release Channel
JTV519
Increased Blood Pressure [PE]
Metabolic Syndrome X
Weighing Patient
Myocardial Infarction
Premature Ventricular Contractions
Epidemiology
Insulin Resistance
Paper Details
References
  • References66
  • Citations3
12345...

Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?

Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy

Apr 5, 2012

U Deniz Dincer

PMID: 22563249

DOI: 10.2147/dmso.s30005

Abstract

Metabolic syndrome is characterized by a combination of obesity, hypertension, insulin resistance, dyslipidemia, and impaired glucose tolerance. This multifaceted syndrome is often accompanied by a hyperdynamic circulatory state characterized by increased blood pressure, total blood vol...read more

Mentioned in this Paper

Cerebral Arterial Diseases
Ryanodine Receptor Calcium Release Channel
JTV519
Increased Blood Pressure [PE]
Metabolic Syndrome X
Paper Details
References
  • References66
  • Citations3
12345...

Get paper from

/papers/cardiac-ryanodine-receptor-in-metabolic-syndrome/22563249